Literature DB >> 1713109

Evidence for facilitatory and inhibitory muscarinic receptors on postganglionic sympathetic nerves in mouse isolated atria.

M Cost1, H Majewski.   

Abstract

1. McNeil A 343 (10 microM-30 microM) enhanced the fractional stimulation-induced (S-I) outflow of radioactivity from mouse isolated atria which had been incubated with [3H]-noradrenaline. The enhancing effect of McNeil A 343 was not altered by hexamethonium (300 microM) suggesting that it was not due to an action at nicotinic receptors. It is also unlikely that McNeil A 343 enhanced the S-I outflow of radioactivity in mouse atria by blocking neuronal reuptake of noradrenaline since the effect persisted in the presence of cocaine (30 microM). 2. The facilitatory effect of McNeil A 343 on the S-I outflow of radioactivity was attenuated by atropine (0.3 microM), pirenzepine (0.2 microM or 1.0 microM), dicyclomine (1.0 microM) and methoctramine (1.0 microM) and was thus due to activation of muscarinic receptors. 3. In contrast to the effect of McNeil A 343, another muscarinic receptor agonist, carbachol (3.0 microM) significantly decreased the S-I outflow of radioactivity. The receptors through which McNeil A 343 acts to enhance the S-I outflow of radioactivity appear to be distinct from inhibitory prejunctional muscarinic receptors. The relatively M 1-selective antagonist, pirenzepine (0.2 microM), attenuated the facilitatory effect of McNeil A 343 whereas a higher concentration (1.0 microM) was required to block the inhibitory effect of carbachol. Conversely, the relatively M2-selective antagonist, methoctramine (0.1 microM), blocked the inhibitory effect of carbachol but a higher concentration of methoctramine (1.0 microM) was required to block the facilitatory effects of McNeil A 343. These results tentatively ascribe facilitatory muscarinic receptors as belonging to the Ml subtype and inhibitory muscarinic receptors as belonging to the M2 subtype. 4. The non-selective muscarinic receptor antagonist, atropine, enhanced the S-I outflow of radioactivity, suggesting that there was tonic activation of inhibitory prejunctional muscarinic receptors by endogenous acetylcholine released from parasympathetic nerves. However, pirenzepine (0.03 pM-LO microM) did not decrease the S-I outflow of radioactivity, suggesting that under the conditions of the present study, facilitatory muscarinic receptors are not tonically activated by endogenous acetylcholine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1713109      PMCID: PMC1917992          DOI: 10.1111/j.1476-5381.1991.tb12266.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  An unusual type of sympathetic ganglionic stimulant.

Authors:  A P ROSZKOWSKI
Journal:  J Pharmacol Exp Ther       Date:  1961-05       Impact factor: 4.030

Review 2.  Muscarinic receptor subtypes and the selectivity of agonists and antagonists.

Authors:  N J Birdsall; C A Curtis; P Eveleigh; E C Hulme; E K Pedder; D Poyner; M Wheatley
Journal:  Pharmacology       Date:  1988       Impact factor: 2.547

Review 3.  Muscarinic receptor differentiation.

Authors:  F Mitchelson
Journal:  Pharmacol Ther       Date:  1988       Impact factor: 12.310

4.  Differential blockade of muscarinic receptor subtypes by polymethylene tetraamines. Novel class of selective antagonists of cardiac M-2 muscarinic receptors.

Authors:  C Melchiorre; A Cassinelli; W Quaglia
Journal:  J Med Chem       Date:  1987-01       Impact factor: 7.446

5.  Effects of the muscarinic agonist McN-A-343 on responses to sympathetic nerve stimulation in the rabbit ear artery.

Authors:  M J Rand; B Varma
Journal:  Br J Pharmacol       Date:  1971-11       Impact factor: 8.739

Review 6.  Muscarinic receptor subtypes: a critique of the current classification and a proposal for a working nomenclature.

Authors:  R M Eglen; R L Whiting
Journal:  J Auton Pharmacol       Date:  1986-12

7.  The interaction of McN-A-343 with pirenzepine and other selective muscarine receptor antagonists at a prejunctional muscarine receptor.

Authors:  L K Choo; F Mitchelson; Y M Vong
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-02       Impact factor: 3.000

8.  Methoctramine selectively blocks cardiac muscarinic M2 receptors in vivo.

Authors:  J Wess; P Angeli; C Melchiorre; U Moser; E Mutschler; G Lambrecht
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-09       Impact factor: 3.000

9.  Heterogeneity of presynaptic muscarinic receptors involved in modulation of transmitter release.

Authors:  E S Vizi; O Kobayashi; A Töröcsik; M Kinjo; H Nagashima; N Manabe; P L Goldiner; P E Potter; F F Foldes
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

10.  Binding and functional profiles of the selective M1 muscarinic receptor antagonists trihexyphenidyl and dicyclomine.

Authors:  A Giachetti; E Giraldo; H Ladinsky; E Montagna
Journal:  Br J Pharmacol       Date:  1986-09       Impact factor: 8.739

View more
  13 in total

1.  Role of L- and N-type Ca2+ channels in muscarinic receptor-mediated facilitation of ACh and noradrenaline release in the rat urinary bladder.

Authors:  G T Somogyi; G V Zernova; M Tanowitz; W C de Groat
Journal:  J Physiol       Date:  1997-03-15       Impact factor: 5.182

2.  Distinct mixtures of muscarinic receptor subtypes mediate inhibition of noradrenaline release in different mouse peripheral tissues, as studied with receptor knockout mice.

Authors:  Anne-Ulrike Trendelenburg; Angelika Meyer; Jürgen Wess; Klaus Starke
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

3.  Modulation of (3)H-noradrenaline release by presynaptic opioid, cannabinoid and bradykinin receptors and beta-adrenoceptors in mouse tissues.

Authors:  A U Trendelenburg; S L Cox; V Schelb; W Klebroff; L Khairallah; K Starke
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

4.  Prejunctional muscarine receptors in the rabbit ear artery differ from M1, M2 and M3 muscarine receptors.

Authors:  S A Darroch; L K Choo; F Mitchelson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-03       Impact factor: 3.000

5.  Evidence that M1 muscarinic receptors enhance noradrenaline release in mouse atria by activating protein kinase C.

Authors:  M Costa; M Barrington; H Majewski
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

6.  Interaction of selective compounds with muscarinic receptors at dispersed intestinal smooth muscle cells.

Authors:  E Barocelli; M Chiavarini; V Ballabeni; F Bordi; M Impicciatore
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

7.  The effects of transdermal scopolamine on autonomic nervous activity during sleep.

Authors:  J Alihanka; A Lahdenperä; T Kaila
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

8.  3H-Noradrenaline release from mouse iris-ciliary body: role of presynaptic muscarinic heteroreceptors.

Authors:  Michel Bernhard; Kenneth Takeda; Caroline Keller; Mirko Haslebacher; George N Lambrou; Anne-Ulrike Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-09-16       Impact factor: 3.000

9.  M1 muscarinic receptor-mediated facilitation of acetylcholine release in the rat urinary bladder.

Authors:  G T Somogyi; M Tanowitz; W C de Groat
Journal:  J Physiol       Date:  1994-10-01       Impact factor: 5.182

10.  Evidence for M1 muscarinic cholinoceptors mediating facilitation of noradrenaline release in guinea-pig carotid artery.

Authors:  M A Casado; J Marín; M Salaices
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-10       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.